Status:
COMPLETED
Staphylococcus Lugdunensis Prosthetic Joint Infection
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Staphylococcal Infections
Prosthetic Joint Infection
Eligibility:
All Genders
18+ years
Brief Summary
Staphylococcus lugdunensis is a coagulase-negative staphylococcus belonging to the human commensal cutaneous flora, and has been little studied in the field of prosthetic joint infections. However, it...
Eligibility Criteria
Inclusion
- infection of joint prosthesis (whatever its type) with Staphylococcus lugdunensis defined by the positivity of at least 2 gold-standard samples (joint puncture, intraoperative samples) with S. lugdunensis; OR
- a single positive gold-standard sample or positive blood cultures AND formal clinical, radiological, biological and / or pathological arguments in favor of an infection of joint prosthesis AND absence of other pathogenic agent
Exclusion
- none
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT04409392
Start Date
February 1 2021
End Date
April 1 2021
Last Update
June 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon
Lyon, France, 69004